RenovoRx to host Q4 2025 earnings call

RenovoRx, Inc. has scheduled its fourth quarter and full year 2025 financial results conference call for March 30th at 4:30 p.m. Eastern Time. The company, a life sciences firm focused on developing innovative therapies, will provide updates on its financial performance and key business highlights. Investors and interested parties can participate in the call to gain insights into RenovoRx's progress and future outlook.